introduction of new administrative rules for regulating the pharmaceutical market of Ukraine can lead to a deterioration in the quality of treatment, especially if original drugs are replaced by cheaper analogues.
This is reported by UNN, reports Hooray Inform.
The director of the Tabletka Foundation Vyacheslav Bykov noted that even drugs with identical active substance may differ in effectiveness due to the composition of the excipients.
“Cheaper medicines can contain impurities that increase the risk of adverse reactions, ”he explained. & nbsp; & nbsp; & nbsp;
innovations can lead to leaving the market of a number of vital imported drugs. Bykov believes that manufacturers will lose interest in Ukraine if the working conditions are unprofitable for them.
“Our market will become less attractive to large pharmaceutical companies,” he said.
as a result Patients will face a deficiency of important medicines, and their cost in the black market can increase. & nbsp;
to avoid negative The consequences, experts offer alternative measures, including recognition of registration in the EU sufficient for the import of drugs to Ukraine. The implementation of the Track & Amp; Trace system for combating falsifications is also proposed. This will increase competition, which, in turn, can lead to a decrease in prices and an increase in the availability of high -quality drugs. & Nbsp;
We also reported how a cat decides with whom to sleep: a veterinarian about the features of the thinking of a pets .